Senhance™ Surgical System
In the US:
The Senhance™ Surgical System is intended to assist in the accurate control of laparoscopic instruments for visualization and endoscopic manipulation of tissue including grasping, cutting, blunt and sharp dissection, approximation, ligation, electrocautery, suturing, mobilization and retraction in laparoscopic colorectal surgery and laparoscopic gynecological surgery. The system is indicated for adult use. It is intended for use by trained physicians in an operating room environment in accordance with the Instructions for Use. The device is restricted to sale by or on the order of a physician.
In the EU:
The Senhance™ Surgical System has received a CE Mark according to the Medical Device Directive and is intended to be used for laparoscopic surgery in the abdomen, pelvis and limited uses in the thoracic cavity excluding the heart and greater vessels. The system is indicated for adult use. The device is restricted to sale by or on the order of a physician.
RADIA articulating instrumentation is only currently available in CE Markets. Four manipulator arm configuration is only currently available in CE Markets.
Senhance was developed under a license of the European Commission Joint Research Centre.
© 2017 TransEnterix Surgical, Inc. All rights reserved. Senhance is a trademark of TransEnterix Surgical, Inc.
The SurgiBot System is not available for sale in any market.